UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (6492) 6492
life sciences & biomedicine (5962) 5962
humans (4867) 4867
animals (4208) 4208
signal transduction (2814) 2814
mice (2285) 2285
janus kinase 2 - metabolism (1861) 1861
phosphorylation (1848) 1848
janus kinase 2 (1838) 1838
male (1664) 1664
cell biology (1530) 1530
female (1486) 1486
protein-tyrosine kinases - metabolism (1411) 1411
biochemistry & molecular biology (1397) 1397
signal transduction - drug effects (1395) 1395
stat3 transcription factor - metabolism (1364) 1364
janus kinases - metabolism (1349) 1349
oncology (1209) 1209
biological and medical sciences (1041) 1041
kinases (1028) 1028
cell line, tumor (1023) 1023
janus kinase 2 - genetics (1020) 1020
cells, cultured (985) 985
cell line (978) 978
janus kinase (956) 956
gene expression (931) 931
hematology (915) 915
proteins (906) 906
mutation (867) 867
stat transcription factors - metabolism (867) 867
cytokines (858) 858
apoptosis (854) 854
rats (841) 841
immunology (834) 834
dna-binding proteins - metabolism (822) 822
trans-activators - metabolism (821) 821
janus kinase 1 (747) 747
proto-oncogene proteins (717) 717
research (715) 715
signal transduction - physiology (713) 713
abridged index medicus (690) 690
medical sciences (689) 689
janus kinase 2 - antagonists & inhibitors (594) 594
janus kinase 1 - metabolism (586) 586
analysis (567) 567
research article (567) 567
inflammation (557) 557
cell proliferation (554) 554
middle aged (552) 552
stat3 protein (541) 541
apoptosis - drug effects (530) 530
science & technology - other topics (527) 527
adult (525) 525
genetic aspects (524) 524
phosphorylation - drug effects (522) 522
multidisciplinary sciences (520) 520
tumors (519) 519
cancer (504) 504
protein kinase inhibitors - pharmacology (477) 477
mice, inbred c57bl (475) 475
pharmacology & pharmacy (474) 474
cell proliferation - drug effects (463) 463
blotting, western (460) 460
rodents (453) 453
fundamental and applied biological sciences. psychology (449) 449
health aspects (448) 448
transcription (442) 442
transfection (439) 439
medicine, research & experimental (436) 436
research & experimental medicine (435) 435
aged (432) 432
physiological aspects (425) 425
endocrinology & metabolism (412) 412
medicine (411) 411
jak2 (410) 410
signaling (409) 409
stat5 transcription factor - metabolism (402) 402
enzyme activation (394) 394
stat3 transcription factor (394) 394
stat1 transcription factor - metabolism (392) 392
stat1 transcription factor (389) 389
disease models, animal (379) 379
gene expression regulation (378) 378
stat3 (377) 377
stat3 transcription factor - genetics (373) 373
enzyme inhibitors - pharmacology (370) 370
hemic and lymphatic diseases (366) 366
tyrosine - metabolism (362) 362
cytokines - metabolism (360) 360
tumor cells, cultured (360) 360
rats, sprague-dawley (359) 359
molecular sequence data (357) 357
rna, messenger - metabolism (347) 347
janus kinases - antagonists & inhibitors (345) 345
stat5 transcription factor (344) 344
protein binding (339) 339
janus kinase 3 (331) 331
stem cells (327) 327
mice, knockout (325) 325
science (325) 325
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7433) 7433
Chinese (59) 59
Japanese (34) 34
Portuguese (4) 4
Russian (4) 4
French (2) 2
German (2) 2
Spanish (2) 2
Czech (1) 1
Italian (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 0028-0836, 09/2012, Volume 489, Issue 7414, pp. 155 - 159
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Hematologic and hematopoietic diseases | Chemotherapy | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Myeloproliferative Disorders - enzymology | Phosphorylation | Protein Biosynthesis | Humans | Protein Multimerization | STAT Transcription Factors - metabolism | TYK2 Kinase - metabolism | Janus Kinase 1 - deficiency | TYK2 Kinase - deficiency | Myeloproliferative Disorders - pathology | Janus Kinase 1 - biosynthesis | Gene Knockdown Techniques | Janus Kinase 2 - deficiency | Janus Kinase 1 - metabolism | Granulocytes - drug effects | RNA Interference | Janus Kinase 1 - genetics | Janus Kinase 2 - metabolism | Myeloproliferative Disorders - metabolism | Granulocytes - metabolism | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Cell Line | Janus Kinase 2 - genetics | Myeloproliferative Disorders - drug therapy | Enzyme Activation - drug effects | TYK2 Kinase - biosynthesis | Granulocytes - enzymology | Animals | Signal Transduction - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | HSP90 Heat-Shock Proteins - metabolism | Mice | TYK2 Kinase - genetics | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | Gene mutations | Cancer cells | Dosage and administration | Genetic aspects | Cellular signal transduction | Identification and classification | Physiological aspects | Care and treatment | Research | Myeloproliferative disorders | Cancer | Index Medicus | tyrosine kinase inhibitors | persistence | MPN | JAK2 | resistance
Journal Article
Journal Article
Biochemical journal, ISSN 0264-6021, 06/2009, Volume 420, Issue 3, pp. 345 - 361
Extracellular-signal-regulated kinase (ERK) | Pleiotrophin | Anaplastic large cell lymphoma (ALCL) | Neuroblastoma | Non-small cell lung cancer (NSLCL) | Midkine | Anaplastic lymphoma kinase (ALK) | Inflammatory myofibroblastic tumour (IMT) | Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Oncogene Proteins, Fusion - metabolism | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Neuroblastoma - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung Neoplasms - pathology | Nuclear Proteins - metabolism | Receptor Protein-Tyrosine Kinases | Protein-Tyrosine Kinases - genetics | Models, Biological | Oncogene Proteins, Fusion - genetics | Lymphoma, Large-Cell, Anaplastic - pathology | Neuroblastoma - metabolism | Nuclear Proteins - genetics | Lymphoma, Large-Cell, Anaplastic - metabolism | Neuroblastoma - pathology | Lymphoma, Large-Cell, Anaplastic - genetics | Index Medicus | ALK, anaplastic lymphoma kinase | LTK, leucocyte tyrosine kinase | MUC-1, mucin-1 | IRS-1, IR substrate-1 | PTN, pleiotrophin | TGFβ, transforming growth factor β | neuroblastoma | extracellular-signal-regulated kinase (ERK) | pleiotrophin | ERK, extracellular-signal-regulated kinase | PKB, protein kinase B | Shc, Src homology and collagen homology | TPM, tropomyosin | IMP cyclohydrolase | MK, midkine | MYH9, non-muscle myosin heavy chain | MAM, meprin, A5 protein and receptor protein tyrosine phosphatase mu | NPM, nucleophosmin | mTOR, mammalian target of rapamycin | NIPA, nuclear interacting partner of ALK | RPTP, receptor protein tyrosine phosphatase | inflammatory myofibroblastic tumour (IMT) | DLBCL, diffuse large B-cell lymphoma | FOXO3a, forkhead box O 3a | NF-κB, nuclear factor κB | Shp1, SH2 domain-containing phosphatase 1 | RANBP2, Ran-binding protein 2 | ALCL, anaplastic large cell lymphoma | Dpp, decapentaplegic | FRS2, fibroblast growth factor receptor substrate 2 | LDLa, low-density lipoprotein class A | EGFR, epidermal growth factor receptor | SEC31L1, SEC31 homologue A | GIST, gastrointestinal stromal tumour | RTK, receptor tyrosine kinase | SH2, Src homology 2 | TFG, TRK-fused gene | ATIC, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase | midkine | CLTC, clathrin heavy chain | anaplastic large cell lymphoma (ALCL) | MAPK, mitogen-activated protein kinase | Hen-1, hesitation-1 | MEK, MAPK | PI3K, phosphoinositide 3-kinase | HEK, human embryonic kidney | SCD-2, suppressor of constitutive dauer 2 | Review | EBPβ, CCAAT | CARS, cysteinyl-tRNA synthetase | JNK, c-Jun N-terminal kinase | ERK kinase | Grb2, growthfactor-receptor-bound protein 2 | SCC, squamous cell carcinoma | EML4, echinoderm microtubule-associated protein like 4 | SHH, sonic hedghog | BCR-Abl, breakpoint cluster region-Abl | IR, insulin receptor | ALO17, ALK lymphoma oligomerization partner on chromosome 17 | enhancer-binding protein β | PLCγ, phospholipase Cγ | NSCLC, non-small cell lung cancer | UCN-01, unco-ordinated 1 | non-small cell lung cancer (NSLCL) | Cdc42, cell division cycle 42 | STAT, signal transducer and activator of transcription | anaplastic lymphoma kinase (ALK) | DRG, dorsal root ganglia | MSN, moesin | dALK, Drosophila ALK | IL-3, interleukin-3 | CNS, central nervous system | JAK, Janus kinase | CML, chronic myeloid leukaemia | Jeb, jelly belly | IMT, inflammatory myofibroblastic tumour
Journal Article